Sonali Jhanjee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sonali Jhanjee has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Raka Jain
Formerly at National Drug Dependence, Treatment Centre, All India Institute of Medical Sciences, New Delhi, India
3 shared publications Anju Dhawan
National Drug Dependence Treatment Centre, All India Institute Of Medical Sciences, New Delhi, India
2 shared publicationsHem Sethi
National Drug Dependence Treatment Centre, All India Institute Of Medical Sciences, New Delhi, India
2 shared publications- Rahul Raghav
Molecular Cardiology Research Institute, Tufts Medical Center
2 shared publications Azhar Jabin
Faculty of Unani Medicine, Jamia Hamdard University, New Delhi, 110019, India
1 shared publication- Imamuddin Khan
Department of Psychiatry, RUHS CMS Medical College, Jaipur, Rajasthan, India
1 shared publication
Latest Publications
- Open Access
- 11 February 2026
- Published by SAGE Publications in Indian Journal of Psychological Medicine
A Comparative Study of Sociodemographic, Clinical, and Psychosocial Parameters Between Injecting and Non-injecting Opioid-dependent Males
Background: Opioid use disorder (OUD), particularly injection drug use (IDU), is on the rise and is associated with complications such as blood-borne infections, overdosing, and seizures, among others. Understanding factors distinguishing non-injecting opioid users (NIOU) and IDUs is essential for the development of effective prevention and management strategies. This study aimed to compare sociodemographic, clinical, and psychosocial factors between IDUs and NIOUs. Methods: A cross-sectional study was conducted at a tertiary care center in North India, including 100 opioid-dependent males (50 NIOUs and 50 IDUs). Sociodemographic, clinical, and psychosocial variables were assessed using structured interviews and validated instruments, including the Maudsley Addiction Profile, the severity of dependence scale (SDS), the high-risk behavior scale (HRBS), the sensation seeking scale (SSS), the Barratt Impulsiveness Scale (BIS), and the WHO-ASSIST. Results: IDUs had significantly higher histories of alcohol use, duration of cannabis use, and family history of substance use, and significantly higher scores on HRBS, BIS, and the SSS ( p < .05). WHO-ASSIST and SDS scores were comparable between the groups. IDUs had a substantially higher number of days of heroin use in the last month and days of conflicts with relatives ( p < .05). Mean duration of the transition period from NIOU to IDU was 4 ± 3.3 years. Conclusions: Family history of drug use, higher sensation seeking, impulsivity, and risk-taking behavior were found to be important factors related to IDU. Interventions targeting these factors are essential for preventing the transition from NIOU to IDU.
- 11 February 2026
- Published by SAGE Publications in Indian Journal of Psychological Medicine
Open AccessA Comparative Study of Sociodemographic, Clinical, and Psychosocial Parameters Between Injecting and Non-injecting Opioid-dependent Males
Background: Opioid use disorder (OUD), particularly injection drug use (IDU), is on the rise and is associated with complications such as blood-borne infections, overdosing, and seizures, among others. Understanding factors distinguishing non-injecting opioid users (NIOU) and IDUs is essential for the development of effective prevention and management strategies. This study aimed to compare sociodemographic, clinical, and psychosocial factors between IDUs and NIOUs. Methods: A cross-sectional study was conducted at a tertiary care center in North India, including 100 opioid-dependent males (50 NIOUs and 50 IDUs). Sociodemographic, clinical, and psychosocial variables were assessed using structured interviews and validated instruments, including the Maudsley Addiction Profile, the severity of dependence scale (SDS), the high-risk behavior scale (HRBS), the sensation seeking scale (SSS), the Barratt Impulsiveness Scale (BIS), and the WHO-ASSIST. Results: IDUs had significantly higher histories of alcohol use, duration of cannabis use, and family history of substance use, and significantly higher scores on HRBS, BIS, and the SSS ( p < .05). WHO-ASSIST and SDS scores were comparable between the groups. IDUs had a substantially higher number of days of heroin use in the last month and days of conflicts with relatives ( p < .05). Mean duration of the transition period from NIOU to IDU was 4 ± 3.3 years. Conclusions: Family history of drug use, higher sensation seeking, impulsivity, and risk-taking behavior were found to be important factors related to IDU. Interventions targeting these factors are essential for preventing the transition from NIOU to IDU.
- Open Access
- 27 January 2023
- Published by SAGE Publications in Indian Journal of Psychological Medicine
- Vol. 45 (2) , 117-123
A Review of Intervention Strategies for Areca Nut Use Cessation
Background: Areca nut (AN) is one of the world’s most widely used drugs, especially in Asia-Pacific, causing dependence and multiple adverse health impacts. The International Agency for Research on Cancer (IARC) has classified it as a type-1 carcinogen. Despite evidence of harms, its use is culturally ingrained in many regions worldwide; harm perception is low; and the availability of intervention strategies is limited. Methods: To identify the range and efficacy of interventional studies on AN use cessation, a narrative review of studies published between 1990 and 2021 was undertaken using selected electronic databases (PubMed, Embase, and Scopus). Results: Three types of interventions were identified: educational, psychological, and pharmacological. Overall, educational interventions significantly enhanced knowledge regarding harms related to AN use. Some psychological interventions reported enhancement of motivation to quit as well as helped in reduction/cessation of AN use. Two pharmacological studies on psychiatric patients with depressive disorders and AN use found that antidepressants helped in reducing/cessation of AN use. Conclusion: Overall, the number of interventional studies on AN cessation is limited, and most studies have measured the short-term effects of the intervention. The role of pharmacotherapeutic interventions needs to be evaluated for AN cessation, and evidence-based psychosocial interventions need to be developed for AN cessation. Furthermore, longitudinal research using adequate sample sizes and longer follow-up durations are needed to establish interventions in this important area.
- 27 January 2023
- Published by SAGE Publications in Indian Journal of Psychological Medicine
- Vol. 45 (2) , 117-123
Open AccessA Review of Intervention Strategies for Areca Nut Use Cessation
Background: Areca nut (AN) is one of the world’s most widely used drugs, especially in Asia-Pacific, causing dependence and multiple adverse health impacts. The International Agency for Research on Cancer (IARC) has classified it as a type-1 carcinogen. Despite evidence of harms, its use is culturally ingrained in many regions worldwide; harm perception is low; and the availability of intervention strategies is limited. Methods: To identify the range and efficacy of interventional studies on AN use cessation, a narrative review of studies published between 1990 and 2021 was undertaken using selected electronic databases (PubMed, Embase, and Scopus). Results: Three types of interventions were identified: educational, psychological, and pharmacological. Overall, educational interventions significantly enhanced knowledge regarding harms related to AN use. Some psychological interventions reported enhancement of motivation to quit as well as helped in reduction/cessation of AN use. Two pharmacological studies on psychiatric patients with depressive disorders and AN use found that antidepressants helped in reducing/cessation of AN use. Conclusion: Overall, the number of interventional studies on AN cessation is limited, and most studies have measured the short-term effects of the intervention. The role of pharmacotherapeutic interventions needs to be evaluated for AN cessation, and evidence-based psychosocial interventions need to be developed for AN cessation. Furthermore, longitudinal research using adequate sample sizes and longer follow-up durations are needed to establish interventions in this important area.
- Open Access
- 6 February 2022
- Published by Negah Scientific Publisher in Basic and Clinical Neuroscience Journal
- p. 1-25
Effect of Hydro-Alcoholic Root Extract of Delphinium Denudatum Wall on Mecamylamine-Precipitated Nicotine-Withdrawal and Corticosterone Levels in Rats
This study evaluates the effects of hydro-alcoholic root extract of Delphinium denudatum Wall (Jadwar, family; Ranunculaceae) for its ability to attenuate the nicotine-withdrawal in nicotine-dependent rats. The physical dependence on nicotine was induced in male adult Wistar albino rats (175-250 g) by subcutaneous implantation of Alzet mini osmotic pumps which ...
- 6 February 2022
- Published by Negah Scientific Publisher in Basic and Clinical Neuroscience Journal
- p. 1-25
Open AccessEffect of Hydro-Alcoholic Root Extract of Delphinium Denudatum Wall on Mecamylamine-Precipitated Nicotine-Withdrawal and Corticosterone Levels in Rats
This study evaluates the effects of hydro-alcoholic root extract of Delphinium denudatum Wall (Jadwar, family; Ranunculaceae) for its ability to attenuate the nicotine-withdrawal in nicotine-dependent rats. The physical dependence on nicotine was induced in male adult Wistar albino rats (175-250 g) by subcutaneous implantation of Alzet mini osmotic pumps which ...
- 21 July 2021
- Published by Taylor & Francis in Substance Use & Misuse
- Vol. 56 (11) , 1624-1641
Effectiveness of Interventions Based on Yogic Breathing Practices (IB-YBP) on Substance Use Disorders—A Systematic Review of the Randomized Control Trials and Quasi-Experimental Trials
Interventions based on Yogic Breathing Practices (IB-YBP) have shown promising results for substance use disorders (SUD). Research in this area is methodologically heterogeneous and only a few, but...
- 21 July 2021
- Published by Taylor & Francis in Substance Use & Misuse
- Vol. 56 (11) , 1624-1641
Effectiveness of Interventions Based on Yogic Breathing Practices (IB-YBP) on Substance Use Disorders—A Systematic Review of the Randomized Control Trials and Quasi-Experimental Trials
Interventions based on Yogic Breathing Practices (IB-YBP) have shown promising results for substance use disorders (SUD). Research in this area is methodologically heterogeneous and only a few, but...
- Open Access
- 1 January 2016
- Published by Scientific Scholar in Indian Journal of Medical Research
- Vol. 143 (1) , 25-9
Putting tobacco harm reduction in perspective: is it a viable alternative?
Indian J Med Res, Official publication of Indian Council of Medical Research,India
- 1 January 2016
- Published by Scientific Scholar in Indian Journal of Medical Research
- Vol. 143 (1) , 25-9
Open AccessPutting tobacco harm reduction in perspective: is it a viable alternative?
Indian J Med Res, Official publication of Indian Council of Medical Research,India
- 1 September 2015
- Published by Elsevier in International Journal of Drug Policy
- Vol. 26 (9) , 890-891
Opioid substitution treatment in Tihar prisons, India: Process of implementation
- 1 September 2015
- Published by Elsevier in International Journal of Drug Policy
- Vol. 26 (9) , 890-891
Opioid substitution treatment in Tihar prisons, India: Process of implementation
- Open Access
- 8 August 2015
- Published by Taylor & Francis in Journal of Psychoactive Drugs
- Vol. 47 (4) , 331-335
Biochemical Validation of Self-Reported Smokeless Tobacco Abstinence among Smokeless Tobacco Users: Results from a Clinical Trial of Varenicline in India
The validity of self-reported tobacco use is often questioned given the potential for underestimation of use. This study used data from a double-blind, placebo-controlled clinical trial of varenicline for smokeless tobacco dependence in India to evaluate the accuracy of self-reported smokeless tobacco cessation using biochemical validation procedures and to evaluate correlates of reporting inaccuracy. Smokeless tobacco users attending a dental clinic at AIIMS were randomized to placebo or varenicline; all participants received counseling. Detailed smokeless tobacco use was recorded and abstinence was defined as cotinine-verified 7-day point prevalence cessation (cotinine < 50 ng/ml) and breath CO > 10 ppm at the end of 12 weeks of treatment. One-half of study completers (82/165) self-reported abstinence. Biochemical verification confirmed that (65.9%) subjects provided accurate self-reports while (34.1%) participants underreported tobacco use. These data indicate poor agreement between self-reported and biochemically confirmed abstinence (κ = −0.191). Underreporters of tobacco use had significantly higher baseline cotinine (p < 0.05), total craving (p < 0.012), and negative reinforcement craving (p < 0.001) vs. those whose self-reports were correctly verified. These findings provide evidence to support the need for biochemical validation of self-reported abstinence outcomes among smokeless tobacco users in cessation programs in India and identify high levels of pretreatment cotinine and craving levels as potential correlates of false reporting.
- 8 August 2015
- Published by Taylor & Francis in Journal of Psychoactive Drugs
- Vol. 47 (4) , 331-335
Open AccessBiochemical Validation of Self-Reported Smokeless Tobacco Abstinence among Smokeless Tobacco Users: Results from a Clinical Trial of Varenicline in India
The validity of self-reported tobacco use is often questioned given the potential for underestimation of use. This study used data from a double-blind, placebo-controlled clinical trial of varenicline for smokeless tobacco dependence in India to evaluate the accuracy of self-reported smokeless tobacco cessation using biochemical validation procedures and to evaluate correlates of reporting inaccuracy. Smokeless tobacco users attending a dental clinic at AIIMS were randomized to placebo or varenicline; all participants received counseling. Detailed smokeless tobacco use was recorded and abstinence was defined as cotinine-verified 7-day point prevalence cessation (cotinine < 50 ng/ml) and breath CO > 10 ppm at the end of 12 weeks of treatment. One-half of study completers (82/165) self-reported abstinence. Biochemical verification confirmed that (65.9%) subjects provided accurate self-reports while (34.1%) participants underreported tobacco use. These data indicate poor agreement between self-reported and biochemically confirmed abstinence (κ = −0.191). Underreporters of tobacco use had significantly higher baseline cotinine (p < 0.05), total craving (p < 0.012), and negative reinforcement craving (p < 0.001) vs. those whose self-reports were correctly verified. These findings provide evidence to support the need for biochemical validation of self-reported abstinence outcomes among smokeless tobacco users in cessation programs in India and identify high levels of pretreatment cotinine and craving levels as potential correlates of false reporting.
- 1 April 2012
- Published by SAGE Publications in Substance Abuse
- Vol. 33 (2) , 99-102
Concordance between Urinary Cotinine Levels and Self-Reported Tobacco Use among Drug-Dependent Persons: A Pilot Study
Self-reported drug use is a principle measure in the evaluation of treatment outcome. As there have been concerns about the accuracy of self-reporting, it is necessary to establish its validity by an objective method. The aim of the study was to examine the concordance between urinary cotinine concentrations and self-reported tobacco use among drug dependents seeking treatment at National Drug Dependence Treatment Centre, AIIMS, New Delhi, India. Eighty consecutive male drug addicts attending the OPD at National Drug Dependence Treatment Centre were interviewed by the clinician. Their tobacco as well as drug use history was recorded, and thereafter their urine sample was analyzed for drug testing. Mean age of the subjects was found to be 33 years (SD: 10). Urinalysis showed high concentration of cotinine (mean ± SD: 586.40 ± 222.15 ng/ml) in 95% of the subjects. High concordance was observed between self-report of tobacco use and urinary cotinine. The quantity of tobacco consumption and FTND scores were also correlated with the urinary cotinine levels. Urinalysis also showed misuse of opioids, benzodiazepines and antihistaminics. The treatment for tobacco use has been given low priority in the de-addiction centers. Tobacco is highly prevalent among the drug abusers. The effectiveness of the treatment program may be increased by using the combination of urine analysis along with self-report.
- 1 April 2012
- Published by SAGE Publications in Substance Abuse
- Vol. 33 (2) , 99-102
Concordance between Urinary Cotinine Levels and Self-Reported Tobacco Use among Drug-Dependent Persons: A Pilot Study
Self-reported drug use is a principle measure in the evaluation of treatment outcome. As there have been concerns about the accuracy of self-reporting, it is necessary to establish its validity by an objective method. The aim of the study was to examine the concordance between urinary cotinine concentrations and self-reported tobacco use among drug dependents seeking treatment at National Drug Dependence Treatment Centre, AIIMS, New Delhi, India. Eighty consecutive male drug addicts attending the OPD at National Drug Dependence Treatment Centre were interviewed by the clinician. Their tobacco as well as drug use history was recorded, and thereafter their urine sample was analyzed for drug testing. Mean age of the subjects was found to be 33 years (SD: 10). Urinalysis showed high concentration of cotinine (mean ± SD: 586.40 ± 222.15 ng/ml) in 95% of the subjects. High concordance was observed between self-report of tobacco use and urinary cotinine. The quantity of tobacco consumption and FTND scores were also correlated with the urinary cotinine levels. Urinalysis also showed misuse of opioids, benzodiazepines and antihistaminics. The treatment for tobacco use has been given low priority in the de-addiction centers. Tobacco is highly prevalent among the drug abusers. The effectiveness of the treatment program may be increased by using the combination of urine analysis along with self-report.